Tetsuro Ishii, University of Tsukuba, Japan Copyright 2014 Berndt, Lillig and Floh
Conclusion SGLT-2 inhibitors and GLP-1 receptor agonists reduce the risk of major cardiovascular events, heart failure, and stroke in type 2 diabetes patients, regardless of metformin use
Is there scientific evidence that semaglutide + B12 works better than semaglutide alone
This angiotensin-based small molecule may be efficacious as a treatment for neurodegenerative diseases
Weight Loss and Cholesterol: The Connection Explained Weight loss is one of the most powerful interventions for improving cholesterol levels, and semaglutide's primary action is appetite suppression that leads to sustained weight reduction
AI is accelerating this shift, powering quiz-based recommendations, wearable integrations, and data-driven insights that make personalization scalable and engaging